FDA Inspection 1062457 — Mindray DS USA, Inc.

Mindray DS USA, Inc. — FEI 2221819

The FDA completed an inspection of Mindray DS USA, Inc. on Apr 20, 2018 in Mahwah, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 20, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Mahwah, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.